You deserve the best care

We find cost-effective drug and the best pharmacy plan for you.

What we help

Find affordable drugs for uninsured or underinsured customers; Find the best pharmacy plan based on customers’ needs; Support medication safety and mental health with AI powered and pharmacist-led consultation focusing on pharmacogenomics.

Who we are

We are a group of people with abundant experience in hospital, pharmacy, private and government health insurance, and AI/data science industries. Healthcare is expensive and it shouldn’t be. We help customers find most effective and affordable medications.

Drug information

We perform evidence-based analysis of newly approved or marketed specialty drugs and compare their cost and effectiveness. Provide information regarding free or discounted program for expensive medication. We are here to help you improve your health outcome and reduce cost.

FDA defines that a biosimilar drug is a biologic product that is highly similar to an existing FDA-approved reference drug and has no clinically meaningful difference from the reference drug. It is considered interchangeable to the reference product.

Due to challenges held up by drug manufacture patents, United States has been slow in using biosimilar drugs. There are currently around 40 approved biosimilar drugs including those categorized as immunology, oncology, endocrinology, and ophthalmology drugs. Among all the therapeutical areas, inflammatory bowel disease, oncology, growth factor, and rheumatoid arthritis have the highest use of biosimilars. Rituximab, Infliximab, filgrastim, and pegfligrastim are the reference products having interchangeable biosimilars that are used most often in clinical settings.

Although there are some barriers to adopt biosimilars, it has seen an increase in implementing of biosimilars due to significant lower cost than the reference drugs. More and more biosimilars are expected to be used with coverage by payers, organization alignment, and physician and patient engagement.

Healthcare organizations are closely monitoring the financial opportunity and patient satisfaction when adopting biosimilars. Although formulary decisions made by the payer play a key role influencing prescribing, patient-centric performance is critical to implementing biosimilars.

We will introduce current most often used biosimilar drugs in our future blogs and how patients can benefit from using those biosimilars compared to the reference products.

Biosimilar drugs information sourced from

Featured Work

“I could not be happier to use RxEncounter’s resources to find the best pharmacy plan to lower my overall healthcare cost.”


“I am very interested in pharmacogenomics. This is a great and useful website which helps me to find the personalized medication.”


“I was able to find the affordable drugs using the information provided by RxEncounter.”


We are with you to find the best care.

We advocate personalized medication by providing information of affordable pharmacy plan and cost-effective drugs.